Emodin inhibits breast cancer cell proliferation through the ERa-MAPK/Akt-Cyclin D1/Bcl-2 signaling pathway

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 15, 2014, Pages 6247-6251

  Sui, Jia Qi ^a   Xie, Kun Peng ^a   Zou, Wei ^a   Xie, Ming Jie ^a  

^a LIAONING NORMAL UNIVERSITY   (China)

Author keywords

Breast cancer; Emodin; Estrogen receptora; Proliferation; Signalling pathways

Indexed keywords

CCND1 PROTEIN, HUMAN; CYCLIN D1; EMODIN; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN KINASE INHIBITOR;

APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CELL PROLIFERATION; DRUG EFFECTS; FEMALE; FLOW CYTOMETRY; GENETICS; HUMAN; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL CYCLE; CELL PROLIFERATION; CYCLIN D1; EMODIN; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; FLOW CYTOMETRY; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 84906268587     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.15.6247     Document Type: Article

References (17)

1. Borner C, Martinou I, Mattmann C, et al (2004). The protein bcl-2 alpha does not require membrane attachment but two conserved domains to suppress apoptosis. J Cell Biol, 126, 1059-68.
2. Coombes RC, Kilburn LS, Snowdon CF, et al (2007). Survival and safety of exemestane versus tamoxifen after 2-3years'tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. Lancet, 369, 559-70.
3. Chakraborty AK, Welsh A, Digiovanna MP (2010). Co-targeting the insulin-like growth factor I receptor enhances growthinhibitory and pro-apoptotic effects of anti-estrogens in human breast cancer cell lines. Breast Cancer Res Treat, 120, 327-35.
4. He L, Bi JJ, Guo Q, Yu Y, Ye XF (2012). Effects of emodin extracted from Chinese herbs on proliferation of non-small cell lung cancer and underlying mechanisms. Asian Pac J Cancer Prev, 13, 1505-10.
5. Izadi P, Mehrdad N, Foruzandeh F, Reza NM (2012). Association of poor prognosis subtypes of breast cancer with estrogen receptor alpha methylation in Iranian women. Asian Pac J Cancer Prev, 13, 4113-7.
6. Jaafar H, Abdullah S, Murtey MD, Idris FM (2012). Expression of Bax and Bcl-2 in tumour cells and blood vessels of breast cancer and their association with angiogenesis and hormonal receptors. Asian Pac J Cancer Prev, 13, 3857-62.
7. Kong EH, Pike AC, Hubbard RE (2003). Structure and mechanism of the estrogen receptor. Biochem Soc Trans, 31, 56-9.
8. Kaufmann M, Jonat W, Hilfrieh J, et al (2007). Improved overall survival in postmenopausal women with early breast cancer after anastrozole initiated after treatment with tamoxifen compared with continued tamoxifen: the ARNO 95 study. J Clin Oncol, 25, 2664-70.
9. Liu C, Liu YX, Lv Y (2006). Inhibitory effects of emodin on proliferation of human lymphocytes in vitro. J Fourth Mil Med Univ, 27, 2251-2.
10. Lu H, Chen D, Hu LP, et al (2013). Estrogen receptor alpha gene polymorphisms and breast cancer risk: a case-control study with meta-analysis combined. Asian Pac J Cancer Prev, 14, 6743-9.
11. Mendoza RA, Enriquez MI, Mejia SM, Moody EE, Thordarson G (2011). Interactions between insulin-like growth factor-I, estrogen receptor-α (ERα) and ERβ in regulating growth/apoptosis of MCF-7 human breast cancer cells. J Endocrinol, 208, 1-9.
12. Ma X, Xie KP, Shang F, et al (2012). Wogonin inhibits IGF-1-stimulated cell growth and estrogen receptor a expression in breast adenocarcinoma cell and angiogenesis of chick chorioallantoic membrane. Acta Physiol Sin, 64, 207-12.
13. Shi XJ, Au WW, Wu KS, Chen LX, Lin K (2014). Mortality characteristics and prediction of female breast cancer in China from 1991 to 2011. Asian Pac J Cancer Prev, 15, 2785-91.
14. Takahashi-Yanaga F, Sasaguri T (2008). GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy. Cell Signal, 20, 581-9.
15. Yamaguchi Y (2007). Microenvironmental regulation of estrogen signals in breast cancer. Breast Cancer, 14, 175-81.
16. Yao Y, Zhou Q (2010). A novel antiestrogen agent shikonin inhibits estrogen-dependent gene transcription in human breast cancer cells. Breast Cancer Res Treat, 121, 233-40.
17. Zhang S, Li X, Burghardt R, Smith R 3rd, Safe SH (2005). Role of estrogen receptor (ER)alpha in insulin-like growth factor(IGF)-1-induced responses in MCF-7 breast cancer cells. J Mol Endocrinol, 35, 433-47.